NCT01553773View on ClinicalTrials.gov

Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Atrophy
Interventions
DRUG

isoflavone

treatments: a gel with 17-β estradiol 0.01% (n = 15) and a gel with isoflavones (genistein 4%). The gels were applied once per day. the lenght of treatment was 24 weeks.

DRUG

Estradiol

a gel with 17-β estradiol 0.01%. Once per day. The lenght of treatment was 24 weeks.

Trial Locations (1)

04021003

Department of Gynecology - UNIFESP, São Paulo

All Listed Sponsors
collaborator

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

OTHER_GOV

lead

Federal University of São Paulo

OTHER

NCT01553773 - Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment | Biotech Hunter | Biotech Hunter